Skip to main content
. Author manuscript; available in PMC: 2010 May 19.
Published in final edited form as: Stem Cells. 2009 Apr;27(4):971–979. doi: 10.1002/stem.12

Table 2.

Left ventricular function in sham, untreated (PBS), control MSC treated (MSC), and Akt-MSC treated animals at 72 hours and 2 weeks after myocardial infarction

Sham
(n=9)
PBS
(n=7)
MSC
(n=7)
Akt-MSC
(n=9)
72 hours
DevP (mmHg) 98 ± 2 60 ± 5* 68 ± 3* 86 ± 3*#
RPP (mmHg/min) 29,131 ± 733 18,487 ± 1,588* 21,661 ± 1,159* 25,656 ± 948*#
+dP/dt (mmHg/min) 3,027 ± 63 1,893 ± 93* 1,988 ± 93* 2,760 ± 114#
−dP/dt (mmHg/min) 2,008 ± 72 1,254 ± 65* 1,280 ± 89* 1,919 ± 71#
2 weeks
DevP (mmHg) 102 ± 4 55 ± 6* 61 ± 2* 84 ± 5*#
RPP (mmHg/min) 31,148 ± 2.080 18,675 ± 2,927* 18,790 ± 1,280* 25,089 ± 2,131*#
+dP/dt (mmHg/min) 2,894 ± 69 1,866 ± 172* 1,824 ± 66* 2,406 ± 135*#
−dP/dt (mmHg/min) 1,868 ± 233 1,195 ± 167* 1,094 ± 103* 1,712 ± 170#

Values expressed as average ± SE

*

p<0.05 vs sham

#

p<0.05 vs PBS

p<0.05 vs control MSC.

Abbreviations: Akt-MSC, MSCs overexpressing Akt1; DevP, LV developed pressure; þdP/dt, maximum values within a beat of the first derivative of left ventricular pressure; −dP/dt, minimum values within a beat of the first derivative of left ventricular pressure; MSC, mesenchymal stem cells; PBS, phosphate-buffered saline; RPP, rate-pressure product.

HHS Vulnerability Disclosure